Investor Stock List
Ranked #3,650 of 8,699 institutional investors

Jones Hill Capital LP

New York, NY

$495M
US stock portfolio at live prices · today −$4.7M (−0.94%)
Live prices, last trade 11:28 AM ET
Value at quarter end (Q3 2026)
$589M
Change from Q2 2026
+$118.8M (+25.26%)
Positions
30 · 17 new, 14 sold out
Filed
Nov 13, 2026

Not counted in the ranking: none$57.4M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
BMRN 14.4%BCRX 10.5%TVTX 9.34%SUPN 8.97%CELC 4.25%
StockSharesValue, live% of portfoliovs Q2 2026
BMRN BioMarin Pharmaceutical Inc.1,171,859$71.5M14.4%Reduced −18%
BCRX BioCryst Pharmaceuticals, Inc.7,083,300$51.9M10.5%New
TVTX Travere Therapeutics, Inc.959,634$46.3M9.34%New
SUPN Supernus, Inc.1,526,685$44.4M8.97%New
CELC Celcuity Inc.382,901$21.0M4.25%New
TRVI Trevi Therapeutics, Inc.1,447,156$19.3M3.91%Added +8%
NUVB Nuvation Bio Inc.4,486,986$17.1M3.45%New
VERA Vera Therapeutics, Inc.652,218$16.8M3.40%New
IONS Ionis Pharmaceuticals, Inc.599,826$16.5M3.33%New
INSM Insmed Incorporated106,528$15.5M3.13%Reduced −13%
RLMD Relmada Therapeutics, Inc.5,237,628$15.1M3.05%Added +43%
NBIX Neurocrine Biosciences, Inc.83,426$12.8M2.59%New
IMCR Immunocore Holdings plc384,278$10.2M2.07%Reduced −25%
ABVX ABIVAX Société Anonyme142,558$9.8M1.99%New
BCAX Bicara Therapeutics Inc.1,064,233$9.5M1.93%Added +19%
ACRS Aclaris Therapeutics, Inc.2,504,651$8.7M1.76%Added +42%
ERAS Erasca, Inc.610,118$8.6M1.73%New
CAPR Capricor Therapeutics, Inc.892,532$7.0M1.42%Added +112%
DNTH Dianthus Therapeutics, Inc.80,017$6.7M1.35%Added +40%
NGNE Neurogene Inc.217,700$4.9M1.00%New
DYN Dyne Therapeutics, Inc.300,900$4.8M0.97%New
SGMT Sagimet Biosciences Inc.502,587$4.6M0.92%New
AVLN Avalyn Pharma Inc.126,744$3.5M0.71%New
ATTO Attovia Therapeutics, Inc.182,295$2.8M0.56%New
CRBP Corbus Pharmaceuticals Holdings, Inc.886,428$2.0M0.40%Added +36%
LXEO Lexeo Therapeutics, Inc.593,737$1.9M0.38%New
OLMA Olema Oncology, Inc.206,397$1.5M0.30%Reduced −64%
TNXP Tonix Pharmaceuticals Holding Corp.563,739$1.4M0.28%Reduced −10%
PHAT Phathom Pharmaceuticals, Inc.276,830$1.3M0.27%Added +71%
TENX Tenax Therapeutics, Inc.122,169$158K<0.1%New

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
GILD Gilead Sciences, Inc.343,043$58.0M
ARQT Arcutis Biotherapeutics, Inc.1,089,701$29.2M
AMLX Amylyx Pharmaceuticals, Inc.894,058$23.2M
MDGL Madrigal Pharmaceuticals, Inc.52,545$20.5M
ANIP ANI Pharmaceuticals, Inc.233,808$16.0M
XENE Xenon Pharmaceuticals Inc.367,900$13.7M
VRTX Vertex Pharmaceuticals Incorporated11,123$5.8M
VIR Vir Biotechnology, Inc.659,213$5.7M
ORIC ORIC Pharmaceuticals, Inc.747,313$5.7M
IMUX Immunic, Inc.539,814$3.9M
SNDX Syndax Pharmaceuticals, Inc.340,000$3.0M
ELVN Enliven Therapeutics, Inc.49,850$2.3M
GPCR Structure Therapeutics Inc.40,567$672K
QUIT Achieve Life Sciences, Inc.26,760$153K